期刊文献+

沈元良主任治疗重症肝炎经验撷英 被引量:2

Experience in Director Shen Yuanliang Treating Severe Hepatitis
下载PDF
导出
摘要 [目的]对沈元良主任中医师治疗重症肝炎的经验进行总结。[方法]根据对重症肝炎病因病机、治则治法的分析,归纳总结重症肝炎的要点,并通过1例案例具体说明。[结果]重症肝炎的病因主要为"湿邪""热邪""毒邪""瘀血",以清热利湿、解毒、化瘀为主要治法。[结论]名老中医药专家沈元良主任运用清热利湿,化瘀解毒法治疗重症肝炎,取得较好临床疗效,对临床实践具有启示意义,具有推广应用价值。 Objective] To sum up director doctor Sheng Yuanliang ’s experience in treating severe hepatitis. [Method] Through analyzing the treating rules,causa morbi and mechanism of severe hepatitis,it sums up the key points of data of severe hepatitis,with 1 case for detailed explanation. [Result] The reason of the disease is mainly“damp,heat and toxin evils”,with corresponding therapies of removing heat to promote dieresis ,removing toxin and stasis. [Conclusion] The famous TCM doctor Shen Yuangliang’s applying clearing heat to promote dieresis,removing stasis and toxin to treat severe hepatitis,gets good clinical effect,having enlightenment meaning to clinical practice,with promotion value.
作者 公培强
机构地区 绍兴市中医院
出处 《浙江中医药大学学报》 CAS 2014年第11期1296-1298,共3页 Journal of Zhejiang Chinese Medical University
基金 浙江省中医药管理局课题(2012ZB156)~~
关键词 重症肝炎 清热利湿 解毒 化瘀 沈元良 名医经验 severe hepatitis clear heat to promote dieresis remove toxin disperse stasis Shen Yuanliang famous doctor's experience
  • 相关文献

参考文献6

二级参考文献30

  • 1Institute of Infectious Diseases, Zhejiang University School of Medicine, Hangzhou 310003, China (Hou W, Liu KZ, Li MW and Wo JE).Effect of IFNα-2a on Fas expression and apoptosis rate of peripheral blood cytotoxic T cells in patients with hepatitis B[J].Hepatobiliary & Pancreatic Diseases International,2005,4(3):403-405. 被引量:4
  • 2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:829
  • 3Matsumura H,Shimizu Y,Ohsawa Y. Necrotic death pathway in Fas receptor signaling[J].Journal of Cell Biology,2009,(13):1247-1256.
  • 4Hetz H,Hoetzenecker K,Hacker S. Caspase-cleaved cytokeratin 18 and 20S proteasome in liver degeneration[J].Journal of Clinical Laboratory Analysis,2007,(02):277-281.
  • 5Gregory PA,Bracken CP,Bert AG. MicroRNAs as regulators of epithelial-mesenchymal transition[J].Cell Cycle,2008,(22):3112-3118.
  • 6Kitani A,Xu L. Regulatory T cells and the induction of IL-17[J].Mucosal Immunol,2008,(Suppl l):43-46.
  • 7Ron D,Walter P. Signal integration in the endoplasmic reticulum unfolded protein response[J].Nature Reviews Molecular Cell Biology,2009,(07):519-529.
  • 8Korn T,Bettelli E,Oukka M. IL-17 and Th17 Cells[J].Annual Review of Immunology,2009,(05):485-517.
  • 9Puthalakath H,O′Reilly LA,Gunn P. ER stress triggers apoptosis by activating BH3-only protein Bim[J].Cell,2007,(11):1337-1349.
  • 10Dunn C,Brunetto M,Reynolds G. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage[J].Journal of Experimental Medicine,2007,(08):667-680.

共引文献59

同被引文献9

  • 1中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:54-58.
  • 2中华人民共和国卫生部.涉及人的生物医学研究伦理审查办法(试行)[S].(2007-03-26)[2010-04-05].http://www.moh.gov.cn/qjjys/s3581/200804/b9f1bfee4ab344ec892e68097296e2a8.shtml.
  • 3程刚,江应安,武渝忠,等复方甘草酸苷等联合中医药辨证治疗慢性乙型重症肝炎20例[C].//世界中联第五届肝病国际学术大会论文集.2013:262-264.
  • 4井立华.重症肝炎疾病的治疗和预防[J].医药前沿,2013,17(34):351.
  • 5程刚,江应安,武渝忠,等.复方甘草酸苷等联合中医药辨证治疗慢性乙型重症肝炎20例[R].世界中联第五届肝病国际学术大会,2013.
  • 6寇义华,卢军利.茵陈对黄疸型肝炎的疗效观察[J].中国医药导刊,2011,13(5):836-837. 被引量:9
  • 7代巧妹,李冀,颜培宇.紫草素免疫调节作用研究进展[J].中医药信息,2012,29(6):116-118. 被引量:21
  • 8高海丽,梁海军,王新伟,杨道坤,乔汉臣.晚期重症肝炎患者合并肝肾综合征治疗效果的研究[J].中华医院感染学杂志,2014,24(6):1455-1457. 被引量:17
  • 9病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1):56-62. 被引量:1826

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部